These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8133663)

  • 21. Fatty acid oxidation disorders: outcome and long-term prognosis.
    Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):501-6. PubMed ID: 20049534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective newborn screening of inborn errors of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain.
    Golbahar J; Al-Jishi EA; Altayab DD; Carreon E; Bakhiet M; Alkhayyat H
    Mol Genet Metab; 2013; 110(1-2):98-101. PubMed ID: 23916421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.
    Waisbren SE; Landau Y; Wilson J; Vockley J
    Dev Disabil Res Rev; 2013; 17(3):260-8. PubMed ID: 23798014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders.
    Coates PM
    Eur J Pediatr; 1994; 153(7 Suppl 1):S49-56. PubMed ID: 7957387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition and management of fatty acid oxidation defects: a series of 107 patients.
    Saudubray JM; Martin D; de Lonlay P; Touati G; Poggi-Travert F; Bonnet D; Jouvet P; Boutron M; Slama A; Vianey-Saban C; Bonnefont JP; Rabier D; Kamoun P; Brivet M
    J Inherit Metab Dis; 1999 Jun; 22(4):488-502. PubMed ID: 10407781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.
    Lund AM; Skovby F; Vestergaard H; Christensen M; Christensen E
    J Inherit Metab Dis; 2010 Oct; 33(5):495-500. PubMed ID: 20066495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical protocols concerned with disorders of fatty acid beta oxidation].
    Kania M
    Przegl Lek; 1994; 51(1):25-8. PubMed ID: 8208992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
    Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.
    Bentler K; Zhai S; Elsbecker SA; Arnold GL; Burton BK; Vockley J; Cameron CA; Hiner SJ; Edick MJ; Berry SA;
    Mol Genet Metab; 2016 Sep; 119(1-2):75-82. PubMed ID: 27477829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California.
    Gallant NM; Leydiker K; Tang H; Feuchtbaum L; Lorey F; Puckett R; Deignan JL; Neidich J; Dorrani N; Chang E; Barshop BA; Cederbaum SD; Abdenur JE; Wang RY
    Mol Genet Metab; 2012 May; 106(1):55-61. PubMed ID: 22424739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
    Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
    Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCAD deficiency in Denmark.
    Andresen BS; Lund AM; Hougaard DM; Christensen E; Gahrn B; Christensen M; Bross P; Vested A; Simonsen H; Skogstrand K; Olpin S; Brandt NJ; Skovby F; Nørgaard-Pedersen B; Gregersen N
    Mol Genet Metab; 2012 Jun; 106(2):175-88. PubMed ID: 22542437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
    Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
    BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.